|
HS Code |
770417 |
| Product Name | MEDIHYA Medical Device Grade Sodium Hyaluronate |
| Grade | Medical Device |
| Main Ingredient | Sodium Hyaluronate |
| Purity | High |
| Appearance | White powder |
| Solubility | Water-soluble |
| Molecular Weight Range | Low to High as per specification |
| Sterilization | Sterile |
| Intended Use | Medical applications |
| Storage Condition | Cool, dry place |
| Packaging | Sealed container |
| Country Of Origin | China |
| Allergen Status | Non-allergenic |
| Biocompatibility | Biocompatible |
| Certificate | ISO/CE certified |
As an accredited MEDIHYA Medical Device Grade Sodium Hyaluronate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging is a white, sealed foil pouch labeled "MEDIHYA Medical Device Grade Sodium Hyaluronate," containing 10 grams of fine powder. |
| Shipping | Shipping for MEDIHYA Medical Device Grade Sodium Hyaluronate is conducted in secure, tamper-evident packaging to ensure product integrity. The chemical is transported under controlled temperature conditions, typically in sealed drums or containers, accompanied by proper documentation and safety data sheets, and complies with international regulations for medical-grade substances. |
| Storage | MEDIHYA Medical Device Grade Sodium Hyaluronate should be stored in a cool, dry, and well-ventilated area, away from direct sunlight, heat sources, and moisture. The container must be tightly sealed to prevent contamination. Storage temperature should be kept between 2°C and 25°C. Ensure the product is kept in its original packaging and protected from incompatible substances and physical damage. |
Applications of MEDIHYA Medical Device Grade Sodium Hyaluronate in Industrial ManufacturingMEDIHYA Medical Device Grade Sodium Hyaluronate delivers bioactive viscosity and moisture retention for specialized applications within pharmaceutical, medical device, ophthalmic, wound care, and injectable medical manufacturing streams. As an original manufacturer, we maintain consistent molecular weight distribution, regulatory-certified purity, and traceable quality control throughout all production batches. 1. Injectable Dermal Fillers and Soft Tissue AugmentationIn the soft tissue filler industry, medical device grade sodium hyaluronate serves as a primary active ingredient to form viscoelastic injectable gels for minimally invasive facial aesthetics and reconstructive repairs. Customers require hyaluronate with tightly controlled molecular weight, endotoxin and protein profiles to ensure patient safety, long-lasting gel integrity, and standardized swelling ratios under ISO 13485 and EU MDR guidelines. Manufacturers use careful mixing, crosslinking, and sterilization processes, tailoring polymer network density for target application zones and personalized effects in clinical use. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Ophthalmic Surgical Viscoelastics and Eye DropsOphthalmic manufacturers utilize medical device grade sodium hyaluronate for viscoelastic solutions used during cataract, corneal, and glaucoma surgeries. Its high molecular weight imparts lubricity and surface protection for sensitive ocular tissues. Companies demand sterile production and compliance with pharmacopoeial monographs to minimize risk of inflammation or residual impurities. Specialized grades also formulate lubricating and tear replacement eye drops, where precise viscosity control maximizes patient comfort and residence time in the tear film. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Advanced Wound Care Hydrogel DressingsSodium hyaluronate supports advanced wound care as an active component in hydrogel dressings, where its hydrophilic and biocompatible structure maintains moist wound environments, supports autolytic debridement, and promotes epithelial migration. Industrial formulation processes demand endotoxin limits, non-cytotoxicity endpoints, and compatibility with layered structures incorporating antimicrobials, silver, or alginate. The hydrogel integrates at an early stage, transitioning to film, sheet, or amorphous phases for packing versatility. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Intra-articular Injection Formulas for Osteoarthritis TreatmentTherapeutic viscosupplementation for osteoarthritis relies on intra-articular injection solutions containing medical grade sodium hyaluronate. These products require rigorously controlled molecular weight, strict endotoxin limits, DALY (dose-adjusted local yielding), and biocompatibility verification. Pharmaceutical producers focus on high shear-resistant formulations, using sterile, closed-system mixing to reduce contamination risk. Dosage concentration strongly influences clinical performance and joint lubrication. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Anti-Adhesion Barriers for Surgical ApplicationsSurgical anti-adhesion barriers utilize medical device grade sodium hyaluronate to form biodegradable films or hydrogels that minimize post-operative tissue adhesion. Manufacturers require guaranteed low-residual impurity levels, reproducible viscosity, and non-immunogenic properties to satisfy stringent clinical safety profiles across peritoneal, gynecological, and orthopedic surgeries. The material integrates early in thermo-gelation or film-extrusion steps, enabling downstream film casting, cutting, and sterile packaging. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive MEDIHYA Medical Device Grade Sodium Hyaluronate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Manufacturing sodium hyaluronate for the medical device field is a commitment that calls for experience, oversight, and an understanding of what goes beyond conventional raw material production. Over the years, our plant has become familiar not only with the technical details of fermentation and purification, but with the real-world challenges faced by developers of injectable gels, wound dressings, and ophthalmic devices. MEDIHYA Medical Device Grade Sodium Hyaluronate, available in models such as HY-MD1, HY-MD3, and HY-MD5, reflects the best of our learning and the long hours spent refining every step in the manufacturing, drying, and testing journey.
The journey begins with non-GMO, food-grade strains of Streptococcus zooepidemicus under rigorously controlled fermentation conditions. We use water for injection-grade (WFI) inputs right from the first step. Each vessel undergoes CIP and SIP cycles with process validation to ensure nothing undesirable survives. Over the years, we have watched as even a minor deviation in temperature or pH at this point can introduce unwanted endotoxins or protein fragments, which quickly render a batch unfit for medical purposes. Refined experience has taught us to prioritize steady fermentation kinetics over simple yield increase, trading off some quantity for exceptional batch purity.
Once fermentation winds down, the real test begins. Removal of microbial residues, pyrogens, and protein byproducts requires time and skill—the steps cannot be rushed. Many in our field try to speed this up, but in our experience, any shortcut shows up immediately in subpar test results or—worse—in a lack of clinical stability. Day after day, our team takes samples at every purification checkpoint, checks for transparency, purity, and bioburden, and never signs off a lot until passing innately tough release criteria.
We do not hide behind technical jargon when we talk about specification. Instead, long conversations with medical device developers and regulatory specialists inform what MEDIHYA actually offers. Models such as HY-MD1 (average molecular weight 0.8–1.3 million Da), HY-MD3 (2–3 million Da), and HY-MD5 (3–4 million Da) provide the versatility customers want. Each model comes in powder form, but the true difference rests in purity levels: endotoxin levels stay consistently below 0.05 EU/mg, residual protein below 0.01%, and nucleic acids below 0.1%.
Looking at a batch under the microscope or testing it for viscosity, we want to see tight molecular distribution and a clean, glassy powder, free of odor or discoloration. That demands sustained monitoring, not just at the endpoint, but through each filtration and ultrafiltration cycle. Over the years, we have incorporated more in-line analytics and automated weighing, but no machine replaces visual assessment by trained eyes. There is no mistaking a perfect pour of transparent 1% sodium hyaluronate solution: no flocculation, no foam, nothing but clarity.
Sodium hyaluronate has become indispensable in certain medical devices: ophthalmic surgical aids, viscoelastic agents, intra-articular injection gels, topical wound dressings, and anti-adhesion barriers. Reliability in these applications begins with uncompromised starting material, free from particles and impurities that could either provoke undesired immune responses or degrade under sterilization. Our process has survived regulator audits (from NMPA and TGA to EU QP inspectors), who demand documentation for each cleaning, each raw material lot, and each environmental check.
Viscoelasticity and lubricity are determined not just by molecular weight, but by the overall polydispersity and chain integrity. Batch variations cannot creep in. Too wide a molecular weight distribution, and a gel will not hold its form. Too many residual proteins, and unexpected swelling or irritation may show up in clinical testing. Those are issues experienced by plenty of device manufacturers who moved away from cosmetic or food-grade hyaluronate, only to discover that a true medical grade means something else entirely: traceability, stability, and performance.
Our sodium hyaluronate stands apart from products aimed for the food or cosmetic market at nearly every touchpoint. Our incoming raw material inspections include multiple screenings for purity and pathogen presence using both rapid and classical microbial methods. Production operates under GMP certification, with dedicated cleanroom facilities rated down to ISO Class 5 (Class 100) for the most sensitive steps. Teams wear full gear and follow strict entry protocols.
Most food-grade hyaluronate in the market presents a visually similar powder, but a close look at the source, fermentation controls, and purification reveals the gulf between those products and a medical device grade. The biggest difference shows up in heavy metals and endotoxin content. Food and cosmetic grades often tolerate levels ten or more times higher than any true medical device application will accept. We have seen developers struggle with raw material that passes cosmetic thresholds, but fails to meet medical criteria—especially for critical tests such as USP endotoxin and bioburden.
The drying process also creates a major dividing line. While food-grade production tends to use open-batch ovens, we use closed lyophilizers dedicated solely to hyaluronate, logging shelf temperature and chamber vacuum at every step. Our runs finish only when moisture falls below 10%. That seemingly small step also limits risk of degradation and caking during storage.
Device designers know the scrutiny faced by every excipient and component. Our release documentation includes not just CoA, but full traceability back to every batch of fermentation media, water source, and CIP record. Stability studies at both room temperature and accelerated conditions back up our shelf-life claims, with real data for up to 36 months.
We have worked with teams preparing both 510(k) and CE Mark applications, so we understand the pressure a developer feels to explain every ingredient in their device. Our documentation details animal origin-free status, TSE/BSE risk absence, and allergen statements from the very start. We respond to questions about elemental impurities, microbiological trends, and process validation with direct data rather than guesswork. Our openness comes from experience; device-makers and notified bodies do not forgive hidden surprises.
The value of sodium hyaluronate stretches beyond the technical. We once worked with an ophthalmic device manufacturer struggling with inconsistent gel viscosity, which undermined both surgeon recommendations and patient experience. After trials with our HY-MD3, the consistent molecular weight produced a gel that extruded smoothly every time, with no variation that might prolong procedures or attack corneal tissue. Similarly, wound dressing researchers achieved superior moisture retention with our ultra-pure hyaluronate, avoiding inflammation commonly seen when residual proteins exceed stringent limits.
Clinical partners often return for repeat lots—sometimes years after their initial order—because they know the original certificate will stand up to new regulatory or customer review. We do not allow lot-to-lot drift, because we maintain not just batch sheets, but also process controls tethered to master validation records. Every year, our QA team reviews change control documentation and keeps registered device partners informed about improvements or adjustments.
Producing a reliable medical device excipient does not end at purity or yield. In-house, we place greater focus on physical properties such as hydration rate, viscosity profile, and clarity in solution. Every analyst here holds familiarity with raw benchmark solutions—testing for gel clarity, filterability, and storage stability simultaneously. We have invested in more than just instruments; ongoing in-house analyst training puts theory into daily quality practice.
We also take customer feedback seriously. In three years, one partner’s feedback on injection force prompted us to tune molecular weight controls tighter. This cuts down on batch rejections and enables smoother downstream gel manufacturing. Growing volumes bring risk of process drift, but disciplined monitoring of every step, from seed inoculum ratios to final lyophilization, guards against surprises. Many competitors focus on throughput at the expense of specification or documentation. Our team chooses the slower but surer path, recording lot data in secure digital systems with full audit trails.
The extra care invested in our process leaves an unmistakable mark on the finished product. Whether you are hydrating the hyaluronate to 1% or 2% solution, the difference in appearance and performance is obvious. No excess foam, no erratic viscosity, just a smooth, transparent gel ready for crosslinking, sterilization, or direct filling. Attention extends to the packaging environment itself. Medical device grade requires vacuum-sealed, multi-layer packaging processed just outside the cleanroom, then immediately transferred into cold storage for stability protection.
Customers in the medical device sector expect more than a chemical; they want an integrated service—batch samples, validation support, regulatory mounting, and, most importantly, a risk-free supply chain. Our team holds direct experience in handling requests for both R&D and scale-up volumes, with full transparency from raw material sourcing to finished-goods shipment. Every lot faces mock-recall exercises and annual stability trials, creating confidence not just in specification, but in continuous supply.
We see our role as extending far beyond selling sodium hyaluronate. Device-manufacturing partners sometimes bring challenges: scaling up for a worldwide launch, validating a new sterilization protocol, or investigating root cause of downstream fogging or impurity spikes. We have responded by expanding our QC and support groups, adding in-house regulatory specialists adept at handling device master files, and setting up material compatibility assays with common device plastics and metals.
Collaboration keeps us grounded. Large multinationals and start-ups alike benefit from access to real scientists, not call centers. Our technical teams have guided dozens of device teams through preclinical and clinical readiness—adjusting grades, providing process validation data, even preparing custom documentation packages according to FDA or EU MDR requirements. We understand that, at this level, documentation is as important as purity.
Device registration and ongoing regulatory maintenance have become more complex every year. We have grown with our customers, adapting processes and raising our own quality standards. ISO 13485 alignment, lot-level traceability, environmental monitoring data, and tailored regulatory support speak to the increasingly global, interconnected requirements of device makers. No shortcuts, no ambiguous batch records, and no omitted test results.
Our medical device grade sodium hyaluronate does not serve only today’s needs. Anticipation of future advances—injectables tuned for longer residence time, devices relying on higher or lower chain length, bioprinting applications—guides our research and manufacturing investments. Continuous feedback loops between our customers, our R&D staff, and our plant engineers keep us advancing. As leaders in this specialized field, we add value not just with purity or performance, but with hands-on help and unwavering commitment to reliability.
From our vantage point, overlooking every vessel and cleanroom, it is clear that medical device grade sodium hyaluronate cannot be manufactured with a commodity mindset. Long-term partnerships grow only from hard-won trust and evidence. Developers, quality assurance experts, and regulatory reviewers come to recognize the difference: rigor not just in the prep room, but in our conversations, our methods, and our willingness to support the innovators who rely on us. A powder’s worth, in the world of medical devices, depends as much on integrity as on chemistry. We are ready for every tough question—and ready to deliver every time.
